FDA Inspection 1123204 — Alabama Center For Reproductive Medicine
The FDA completed an inspection of Alabama Center For Reproductive Medicine on Jan 29, 2020 in Birmingham, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 29, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Birmingham, AL (United States)